Biocon Cash Flow Annual

Trade
BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | Sector: Biotechnology & Drugs
336.35 +5.15 (1.55%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 1,297.80643.00771.60855.90
Depreciation/ Depletion 1,568.801,113.10814.20715.10
Non- Cash Items 1,014.80826.00642.30206.30
Changesin Working Capital -927.50-729.60-1,017.70-651.40
Cashfrom Operating Activities 2,953.901,852.501,210.401,125.90
Capital Expenditures -1,931.60-1,726.30-1,924.80-1,746.30
Other Investing Cash Flow Items Total 927.10-12,555.50225.70-1,878.40
Cashfrom Investing Activities -1,004.50-14,281.80-1,699.10-3,624.70
Financing Cash Flow Items -847.40-485.60-109.60-116.00
Total Cash Dividends Paid -203.00-71.80-0.00
Issuance( Retirement)of Stock Net 30.701,201.6042.50797.70
Issuance( Retirement)of Debt Net -1,313.0012,404.50309.201,882.30
Cashfrom Financing Activities -2,332.7013,048.70242.102,564.00
Foreign Exchange Effects 2.9021.703.307.10
Net Changein Cash -380.40641.10-243.3072.30
Cash Interest Paid 847.40485.60109.60116.00
Cash Taxes Paid 292.30228.60262.00193.80
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts